BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22813547)

  • 1. Autoimmune disease.
    Itani MH; Uthman I
    Lupus; 2012 Oct; 21(12):1370-1. PubMed ID: 22813547
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic lupus erythematosus following HPV immunization or infection?
    Soldevilla HF; Briones SF; Navarra SV
    Lupus; 2012 Feb; 21(2):158-61. PubMed ID: 22235047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune/auto-inflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination in Colombians: a call for personalised medicine.
    Anaya JM; Reyes B; Perdomo-Arciniegas AM; Camacho-Rodríguez B; Rojas-Villarraga A
    Clin Exp Rheumatol; 2015; 33(4):545-8. PubMed ID: 25962455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus vaccine and systemic lupus erythematosus.
    Gatto M; Agmon-Levin N; Soriano A; Manna R; Maoz-Segal R; Kivity S; Doria A; Shoenfeld Y
    Clin Rheumatol; 2013 Sep; 32(9):1301-7. PubMed ID: 23624585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study.
    Mok CC; Ho LY; Fong LS; To CH
    Ann Rheum Dis; 2013 May; 72(5):659-64. PubMed ID: 22589375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination in autoimmune animal models.
    Tomijenovic L; Arango MT; Agmon-Levin N
    Isr Med Assoc J; 2014 Oct; 16(10):657-8. PubMed ID: 25438463
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl.
    Della Corte C; Carlucci A; Francalanci P; Alisi A; Nobili V
    Vaccine; 2011 Jun; 29(29-30):4654-6. PubMed ID: 21596082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines.
    Mitchell TC; Casella CR
    Curr Opin Immunol; 2017 Aug; 47():17-25. PubMed ID: 28728074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations and barriers to vaccination in systemic lupus erythematosus.
    Garg M; Mufti N; Palmore TN; Hasni SA
    Autoimmun Rev; 2018 Oct; 17(10):990-1001. PubMed ID: 30103044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.
    Urowitz MB; Anton A; Ibanez D; Gladman DD
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1517-20. PubMed ID: 22034113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.
    Denny L; Hendricks B; Gordon C; Thomas F; Hezareh M; Dobbelaere K; Durand C; Hervé C; Descamps D
    Vaccine; 2013 Nov; 31(48):5745-53. PubMed ID: 24091311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of chronic epipharyngitis in autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA).
    Hotta O; Tanaka A; Torigoe A; Imai K; Ieiri N;
    Immunol Res; 2017 Feb; 65(1):66-71. PubMed ID: 27592233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of human papillomavirus and human papillomavirus vaccination among rheumatology patients.
    O'Connor MB; Bond U; Phelan MJ
    J Clin Rheumatol; 2010 Oct; 16(7):355. PubMed ID: 20921856
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity of the bivalent human papillomavirus vaccine in adolescents with juvenile systemic lupus erythematosus or juvenile dermatomyositis.
    Heijstek MW; Scherpenisse M; Groot N; Wulffraat NM; Van Der Klis FR
    J Rheumatol; 2013 Sep; 40(9):1626-7. PubMed ID: 23997002
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.
    Grimaldi-Bensouda L; Guillemot D; Godeau B; Bénichou J; Lebrun-Frenay C; Papeix C; Labauge P; Berquin P; Penfornis A; Benhamou PY; Nicolino M; Simon A; Viallard JF; Costedoat-Chalumeau N; Courcoux MF; Pondarré C; Hilliquin P; Chatelus E; Foltz V; Guillaume S; Rossignol M; Abenhaim L;
    J Intern Med; 2014 Apr; 275(4):398-408. PubMed ID: 24206418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
    Perkins RB; Christiansen CL
    Evid Based Med; 2015 Jun; 20(3):116. PubMed ID: 25841246
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.
    Kuroda Y; Nacionales DC; Akaogi J; Reeves WH; Satoh M
    Biomed Pharmacother; 2004 Jun; 58(5):325-37. PubMed ID: 15194169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccine in patients with systemic lupus erythematosus.
    Pellegrino P; Carnovale C; Perrone V; Salvati D; Gentili M; Antoniazzi S; Clementi E; Radice S
    Epidemiology; 2014 Jan; 25(1):155-6. PubMed ID: 24296931
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of systemic lupus erythematosus (SLE) following Human papillomavirus (HPV) vaccination].
    Ito H; Noda K; Hirai K; Ukichi T; Furuya K; Kurosaka D
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(2):145-9. PubMed ID: 27212601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus induced by interferon β1 therapy in a patient with multiple sclerosis.
    Bahri DM; Khiari H; Essouri A; Laadhar L; Zaraa I; Mrabet A; Meddeb N; Sellami S
    Fundam Clin Pharmacol; 2012 Apr; 26(2):210-1. PubMed ID: 21323997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.